English
-
AnalytixInsight Reports 2023 Financial Results and Provides MCTO Status Update
06/01/2024 - 11:13 AM
-
The Chemours Company Temporarily Pauses Titanium Dioxide Production at Altamira, Mexico Site Amid Severe Regional Drought
06/01/2024 - 10:02 AM
-
Generation Mining Files Final Base Shelf Prospectus and Updates Shareholders
06/01/2024 - 08:55 AM
-
06/01/2024 - 08:27 AM
-
Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against Rivian Automotive, Inc. and Certain Executives
06/01/2024 - 08:17 AM
-
06/01/2024 - 08:16 AM
-
Government Regulation Creates Blue Oceans
06/01/2024 - 07:52 AM
-
Inocras Presents Poster for Breast Cancer at 2024 ASCO Annual Meeting, Showing Transformative Impact of WGS-based HRD Testing
06/01/2024 - 07:43 AM
-
Leading Independent Proxy Advisory Firm Institutional Shareholder Services Joins Glass Lewis in Recommending Votes “FOR” ALL Nine WisdomTree Board Nominees
06/01/2024 - 07:39 AM
-
06/01/2024 - 07:30 AM
-
06/01/2024 - 07:30 AM
-
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy
06/01/2024 - 07:00 AM
-
06/01/2024 - 06:32 AM
-
06/01/2024 - 06:29 AM
-
University of Phoenix and Executive Networks Study on Workplace Well-Being Highlights Challenges of Current Approaches in Addressing Mental Health
06/01/2024 - 06:27 AM